REACTIVATION OF THE P53 PATHWAY AND INDUCTION OF APOPTOSIS IN THYROID CARCINOMA CELLS BY THE CELL-PERMEABLE SYNTHETIC PEPTIDE P46, THE SMALL MOLECULE PRIMA-1 OR THE HDM2 INHIBITOR NUTLIN-3: THERAPEUTIC IMPLICATIONS Posted on by Read More